Exactly a month ago I warned that the coronavirus outbreak was going to pop the "Everything Bubble ." I did something fairly subtle. I buried my main message under a whole heap of cow manure. It doesn't make a rat's ass if I was right or wrong about calling for a market ...
Streetwise Reports
|
February 27, 2020
|
EpiPen manufacturer Mylan N.V. announced today that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. Mylan Inc. (MYL:NASDAQ) and Pfizer Inc. (PFE:NYSE) today anno...
Streetwise Reports
|
July 31, 2019
|
Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...
Streetwise Reports
|
October 8, 2019
|
I t's currency. It's luxury. It's even dessert. But those are only the base uses of gold. This is the stuff of gods, big and small. Since the dawn of civilization it has held sway over spirit and soul and what the ancient Egyptians knew then, everyone still knows now: Gold is...
Joao Peixe
|
July 23, 2019
|
It was one of those days that all sexagenarians loathe; you have to go to the doctor, and whether it's the GP (general practitioner) or the dentist or the proctologist, nothing reminds you more rapidly of your advancing age than going to the optometrist. Now, many of ...
Streetwise Reports
|
January 14, 2020
|
(Image via Lexaria Bioscience Corp.) There’s no shortage of excitement over potential COVID-19 vaccines. Just looking at the response to news around these developments is evidence of that, and one Company is working on a transformative, patented tech...
Stockhouse Editorial
|
December 1, 2020
|
After over 40 years in the world of money and markets, I have arrived at the conclusion that aging can be a double-edged sword where the advantages created by many years of experience are many times odiously offset by innate biases that become ingrained over time. It came...
Streetwise Reports
|
March 22, 2019
|
Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills
|
December 3, 2019
|
TOMI Environmental Solutions Inc.'s (TOMZ:OTCQB) products kill pathogens—safely and effectively. Not just the coronavirus: Ebola, MERS, C. diff spores, sepsis, norovirus, anthrax, Staphylococcus, MRSA, Legionnaire's and Zika. The kill list also includes food borne illnes...
Streetwise Reports
|
February 19, 2020
|
(CLICK IMAGE TO PLAY VIDEO) Stockhouse investors know that investment opportunities are opening up in the burgeoning psychedelics space. And while many are called, few are chosen. One company that looks to be the choice of many in the know is Filament Health Co...
Dave Jackson
|
July 12, 2021
|